Teachers Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Teachers Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.7M	Buy	115,896 +8,837	+8%	+$102K	﹤0.01%	2048
2018 Q4	$1.14M	Buy	107,059 +14,580	+16%	+$192K	﹤0.01%	2122
2018 Q3	$1.41M	Buy	92,479 +7,475	+9%	+$109K	﹤0.01%	2148
2018 Q2	$1.04M	Buy	+85,004	New	+$1.07M	﹤0.01%	2312
2016 Q2	–	Sell	-26,668	Closed	-$143K	–	3184
2016 Q1	$143K	Buy	26,668 +4,588	+21%	+$29K	﹤0.01%	2879
2015 Q4	$262K	Hold	22,080	–	–	﹤0.01%	2766
2015 Q3	$181K	Hold	22,080	–	–	﹤0.01%	2905
2015 Q2	$308K	Buy	22,080 +17,074	+341%	+$313K	﹤0.01%	2816
2015 Q1	$120K	Sell	5,006 -48,833	-91%	-$1.1M	﹤0.01%	2996
2014 Q4	$82K	Buy	53,839 +48,833	+975%	+$564K	﹤0.01%	3072
2014 Q3	$64K	Hold	5,006	–	–	﹤0.01%	3089
2014 Q2	$113K	Buy	5,006 +1,446	+41%	+$26.2K	﹤0.01%	3039
2014 Q1	$101K	Buy	+3,560	New	+$132K	﹤0.01%	3027

Other funds holding DRNA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Teachers Advisors's DRNA Position: Q1 2019 in Review

Teachers Advisors increased its Dicerna Pharmaceuticals, Inc. (DRNA) stake by 8.3% in Q1 2019, buying an estimated $102K and bringing the position to 115,896 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

Teachers Advisors first reported a position in DRNA in Q1 2014 and has held it in 13 quarters since. 98 funds tracked by Wall St. Rank hold DRNA as of Q1 2019.

Teachers Advisors held 115,896 shares of Dicerna Pharmaceuticals, Inc. worth $1.7M as of Q1 2019.
Teachers Advisors bought 8,837 Dicerna Pharmaceuticals, Inc. shares in Q1 2019, an estimated $102K.
Dicerna Pharmaceuticals, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2048 holding.
Teachers Advisors first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and has held it in 13 quarters since.
98 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.